We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Blood Sample Collection Cards Used for Screening Newborns

By LabMedica International staff writers
Posted on 07 May 2009
Dried blood spot cards are used to collect and transport blood specimens from newborns, which are later analyzed by public health laboratories. More...
Newborn screening is used to detect congenital disorders, many of which are treatable only when identified during the first days of life. A significant number of these are treatable when detected, but fatal when not.

PerkinElmer, Inc. (Waltham, MA, USA) has entered into a contract with ID Biological Systems (Greenville, South Carolina, USA) to become its exclusive, worldwide distributor for dried blood spot specimen collection cards used by newborn screening programs worldwide. The agreement is intended to deliver a consistent, high-quality supply of sample collection cards designed to customer specifications.

ID Biological Systems will produce the cards using Ahlstrom grade 226 filter paper. They are manufactured according to the Clinical and Laboratory Standards Institute (CLSI) standard for blood collection on filter paper for newborn screening programs. The paper has been successfully tested to the CLSI standard by the U.S. Centers for Disease Control and Prevention (CDC; Atlanta, GA, USA) Newborn Screening Quality program and other third party testing facilities.

"To secure the supply and delivery of U.S. Food and Drug Administration (FDA; Rockville, MD, USA)-approved high quality specimen cards is a priority for PerkinElmer and our newborn screening customers," said Ann-Christine Sundell, president, genetic screening, PerkinElmer. "This agreement expands our offering with a high quality product, and provides IDB Systems with a strong and proven distribution channel for its product."

Gary Resler, health services consultant for the Newborn Screening Program in the State of Washington has been using ID Biological Systems' specimen collection cards for samples processed in his laboratory for the past nine months. "A consistent supply of high quality sample cards is an imperative in a public health laboratory processing hundreds of neonatal samples each day," said Mr. Resler. "ID Biological Systems has delivered this quality and consistency along with a tremendous level of service."

Related Links:

PerkinElmer, Inc.
ID Biological Systems
U.S. Centers for Disease Control and Prevention
U.S. Food and Drug Administration



Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.